Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Program To Provide Access To Defencath® For Adult And Pediatric Patients Using A Catheter To Prevent Central Line-Associated Bloodstream Infections (CLABSIs)

NCT06707480 is registered in ClinicalTrials.gov with CorMedix Therapeutics as lead sponsor.

NCT NCT06707480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06707480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Program To Provide Access To Defencath® For Adult And Pediatric Patients Using A Catheter To Prevent Central Line-Associated Bloodstream Infections (CLABSIs)
Lead sponsor
CorMedix Therapeutics
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

catheter-related bloodstream infection